These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211 [TBL] [Abstract][Full Text] [Related]
7. Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration. Ochoa-Alvarez JA; Krishnan H; Shen Y; Acharya NK; Han M; McNulty DE; Hasegawa H; Hyodo T; Senga T; Geng JG; Kosciuk M; Shin SS; Goydos JS; Temiakov D; Nagele RG; Goldberg GS PLoS One; 2012; 7(7):e41845. PubMed ID: 22844530 [TBL] [Abstract][Full Text] [Related]
8. SRC utilizes Cas to block gap junctional communication mediated by connexin43. Shen Y; Khusial PR; Li X; Ichikawa H; Moreno AP; Goldberg GS J Biol Chem; 2007 Jun; 282(26):18914-21. PubMed ID: 17488714 [TBL] [Abstract][Full Text] [Related]
9. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849 [TBL] [Abstract][Full Text] [Related]
10. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth. Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110 [TBL] [Abstract][Full Text] [Related]
12. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Li X; Jia Z; Shen Y; Ichikawa H; Jarvik J; Nagele RG; Goldberg GS Cancer Sci; 2008 Jul; 99(7):1326-33. PubMed ID: 18422756 [TBL] [Abstract][Full Text] [Related]
13. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines. Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035 [TBL] [Abstract][Full Text] [Related]
14. SRC points the way to biomarkers and chemotherapeutic targets. Krishnan H; Miller WT; Goldberg GS Genes Cancer; 2012 May; 3(5-6):426-35. PubMed ID: 23226580 [TBL] [Abstract][Full Text] [Related]
15. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS. Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957 [TBL] [Abstract][Full Text] [Related]
16. Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation. Teckchandani A; Laszlo GS; Simó S; Shah K; Pilling C; Strait AA; Cooper JA J Cell Sci; 2014 Feb; 127(Pt 3):509-20. PubMed ID: 24284072 [TBL] [Abstract][Full Text] [Related]
17. Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma. Neri S; Ishii G; Hashimoto H; Kuwata T; Nagai K; Date H; Ochiai A Int J Cancer; 2015 Aug; 137(4):784-96. PubMed ID: 25648219 [TBL] [Abstract][Full Text] [Related]
18. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. Krishnan H; Ochoa-Alvarez JA; Shen Y; Nevel E; Lakshminarayanan M; Williams MC; Ramirez MI; Miller WT; Goldberg GS J Biol Chem; 2013 Apr; 288(17):12215-21. PubMed ID: 23530051 [TBL] [Abstract][Full Text] [Related]
19. Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility. Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H Cell Signal; 2013 Apr; 25(4):760-5. PubMed ID: 23266472 [TBL] [Abstract][Full Text] [Related]
20. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases. Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]